Cavusoglu, Y. Et Al. 2014. Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes. EUROPEAN JOURNAL OF HEART FAILURE , vol.16 , 159-160.

Cavusoglu, Y., Gencer, E., Mutlu, F., Nadir, A., Mert, K. U., Morrad, B., ... Eraslan, S.(2014). Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes. EUROPEAN JOURNAL OF HEART FAILURE , vol.16, 159-160.

Cavusoglu, YYuksel Et Al. "Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes," EUROPEAN JOURNAL OF HEART FAILURE , vol.16, 159-160, 2014

Cavusoglu, YYuksel Et Al. "Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes." EUROPEAN JOURNAL OF HEART FAILURE , vol.16, pp.159-160, 2014

Cavusoglu, Y. Et Al. (2014) . "Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes." EUROPEAN JOURNAL OF HEART FAILURE , vol.16, pp.159-160.

@article{article, author={YYuksel Cavusoglu Et Al. }, title={Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes}, journal={EUROPEAN JOURNAL OF HEART FAILURE}, year=2014, pages={159-160} }